BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 876540)

  • 21. Serum CA 125 levels in early pregnancy and subsequent spontaneous abortion.
    Check JH; Nowroozi K; Winkel CA; Johnson T; Seefried L
    Obstet Gynecol; 1990 May; 75(5):742-4. PubMed ID: 2325958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid hCG-specific radioimmunoassay for menstrual aspiration.
    Kosasa TS; Pion RJ; Hale RW; Goldstein DP; Taymor ML; Levesque LA; Kobara TY
    Obstet Gynecol; 1975 May; 45(5):566-8. PubMed ID: 1124174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decline of serum human chorionic gonadotropin and spontaneous complete abortion: defining the normal curve.
    Barnhart K; Sammel MD; Chung K; Zhou L; Hummel AC; Guo W
    Obstet Gynecol; 2004 Nov; 104(5 Pt 1):975-81. PubMed ID: 15516387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The problematic first-trimester pregnancy.
    Deutchman M
    Am Fam Physician; 1989 Jan; 39(1):185-98. PubMed ID: 2536209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The measurement of human chorionic gonadotropin for pregnancy testing.
    Feldkamp CS; Pfeffer WH
    Henry Ford Hosp Med J; 1982; 30(4):207-13. PubMed ID: 7169378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The behavior of serum hCG level in normal and disordered pregnancy--a prognostic factor].
    Arsenow H; Dericks-Tan JS; Taubert HD
    Zentralbl Gynakol; 1991; 113(11):633-8. PubMed ID: 1927109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of the results concerning radioimmunologically active human-chorionic gonadotrophin (RIA HCG) in the serum of women with imminent abortions (author's transl)].
    Talas M; Gazárek F; Stehlíková J; Fingerová H
    Cesk Gynekol; 1978 Jun; 43(5):344-7. PubMed ID: 667992
    [No Abstract]   [Full Text] [Related]  

  • 28. Hormone load tests in the first half of pregnancy--a diagnostic and therapeutic approach.
    Gerhard I; Runnebaum B
    Biol Res Pregnancy Perinatol; 1984; 5(4):157-73. PubMed ID: 6084523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial).
    Dugoff L; Hobbins JC; Malone FD; Porter TF; Luthy D; Comstock CH; Hankins G; Berkowitz RL; Merkatz I; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Vidaver J; D'Alton ME
    Am J Obstet Gynecol; 2004 Oct; 191(4):1446-51. PubMed ID: 15507981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of methods for the prospective identification of early fetal losses in environmental epidemiology studies.
    Sweeney AM; Meyer MR; Aarons JH; Mills JL; LaPorte RE
    Am J Epidemiol; 1988 Apr; 127(4):843-50. PubMed ID: 3354549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of rapid radioimmunoassay for urinary beta-human chorionic gonadotropin (beta hCG-RIA) in early pregnancy.
    Xu RQ; Li YY; Zhou SZ; Fei RT; Liu YH
    Acta Acad Med Wuhan; 1984; 4(2):105-8. PubMed ID: 6204259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated serum HCG level after intravenous LH-RH administration in human pregnancies.
    Egyed J; Gáti I
    Endocrinol Exp; 1985 Mar; 19(1):11-5. PubMed ID: 3886364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imbalance of mononuclear cell infiltrates in the placental tissue from foetuses after spontaneous abortion versus therapeutic termination from 8th to 12th weeks of gestational age.
    Lambropoulou M; Tamiolakis D; Venizelos J; Liberis V; Galazios G; Tsikouras P; Karamanidis D; Petrakis G; Constantinidis T; Menegaki M; Papadopoulos N
    Clin Exp Med; 2006 Dec; 6(4):171-6. PubMed ID: 17191109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Occult pregnancy as a factor in unexplained infertility.
    Block SK
    J Reprod Med; 1978 Oct; 21(4):251-3. PubMed ID: 739480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical abortion in patients with recurrent fetal loss.
    Oka C; Makino T; Itakura I; Hara T; Nozawa S; Iizuka R
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Feb; 43(2):239-40. PubMed ID: 1707432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trophoblastic markers in women using intrauterine contraception.
    Ylikorkala O; Siljander M; Huhtaniemi I; Kauppila A; Seppälä M
    Obstet Gynecol; 1980 Mar; 55(3):329-32. PubMed ID: 6965779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reappraisal of the predictive value of the beta-human chorionic gonadotropin assay in an infertile population.
    Belisle S; Lehoux JG; Brault J
    Fertil Steril; 1979 May; 31(5):492-5. PubMed ID: 446772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of a second consecutive first-trimester spontaneous abortion in women who conceive with menotropins.
    Corsan GH; Kemmann E
    Fertil Steril; 1990 May; 53(5):817-21. PubMed ID: 2110074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human chorionic gonadotropin in uterine and peripheral blood tested with an enzyme-linked immunosorbent assay and a radio-immuno assay in cases of spontaneous abortion.
    Steier JA; Sandvei R; Myking OL
    Acta Obstet Gynecol Scand; 1987; 66(4):355-6. PubMed ID: 2447741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measuring human chorionic gonadotropin for detection of early pregnancy loss.
    Canfield RE; O'Connor JF; Wilcox AJ
    Reprod Toxicol; 1988; 2(3-4):199-203. PubMed ID: 2980346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.